Implications of international drug approval systems on confidentiality of business secrets in the U.S. pharmaceutical industry.
Year: 1998
Type: article
Source: PubMed
Author: J T O'Reilly
Institution: Procter & Gamble (United States)
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W2438547973
